» Authors » George A Macones

George A Macones

Explore the profile of George A Macones including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 398
Citations 5056
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandoval G, Saade G, Hughes B, Clifton R, Reddy U, Bartholomew A, et al.
Obstet Gynecol . 2025 Feb; PMID: 40014859
Our objective was to develop a prediction model for hepatitis C virus (HCV) infection perinatal transmission to improve triage for neonatal follow-up. This was a secondary analysis of HCV antibody-positive...
2.
Shea A, Woolfolk C, Cahill A, Tuuli M, Tita A, Srinivas S, et al.
Am J Obstet Gynecol . 2025 Feb; PMID: 39892837
Background: Postpartum hemorrhage is a leading cause of morbidity and mortality. The use of prophylactic oxytocin in the third stage of labor is globally accepted as standard of care for...
3.
Reddy U, Sandoval G, Tita A, Silver R, Mallett G, Hill K, et al.
Am J Obstet Gynecol MFM . 2024 Oct; 6(12):101508. PMID: 39357802
Background: Following the results of the A Randomized Trial of Induction Versus Expectant Management trial, which demonstrated a reduction in cesarean delivery with no increase in adverse perinatal outcomes after...
4.
Hughes B, Sandoval G, Saade G, Clifton R, Reddy U, Bartholomew A, et al.
Obstet Gynecol . 2024 Aug; 144(4):501-506. PMID: 39173174
Objective: To evaluate the risks of adverse maternal and neonatal outcomes associated with pregnancies complicated by hepatitis C virus (HCV) infection. Methods: This is a secondary analysis of a multicenter...
5.
Perez M, Tuuli M, Tita A, Carter E, Macones G, Harper L
Am J Obstet Gynecol MFM . 2024 Aug; 6(9):101454. PMID: 39095025
No abstract available.
6.
Smid M, Clifton R, Rood K, Srinivas S, Simhan H, Casey B, et al.
Obstet Gynecol . 2024 Jun; 144(2):195-205. PMID: 38857509
Objective: To test whether an individualized opioid-prescription protocol (IOPP) with a shared decision-making component can be used without compromising postcesarean pain management. Methods: In this multicenter randomized controlled noninferiority trial,...
7.
Gyamfi-Bannerman C, Clifton R, Tita A, Blackwell S, Longo M, de Voest J, et al.
JAMA . 2024 Apr; 331(19):1629-1637. PMID: 38656759
Importance: The Antenatal Late Preterm Steroids (ALPS) trial changed clinical practice in the United States by finding that antenatal betamethasone at 34 to 36 weeks decreased short-term neonatal respiratory morbidity....
8.
Saucedo A, Macones G, Cahill A, Harper L
Am J Perinatol . 2024 Apr; 41(15):2033-2039. PMID: 38648851
Objective:  Following the release of A Randomized Trial of Induction versus Expectant Management (ARRIVE) trial, the induction of labor at 39 weeks has increased in the United States. The risk...
9.
Cahill A, Macones G
Am J Obstet Gynecol . 2024 Mar; 230(3S):S876-S878. PMID: 38462261
Although the optimal length of the second stage of labor to minimize maternal and neonatal morbidities and optimize spontaneous vaginal delivery is not known, available evidence suggests that increasing length...
10.
Saucedo A, Tuuli M, Gregory W, Richter H, Lowder J, Woolfolk C, et al.
Matern Child Health J . 2024 Mar; 28(7):1228-1233. PMID: 38441866
Objective: To determine intrapartum factors associated with perineal laceration at delivery. Methods: This was a planned secondary analysis of a multicenter randomized clinical trial of delayed versus immediate pushing among...